Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

A study identifies beta-synuclein in blood as a potential early biomarker for Alzheimer’s disease. This protein’s levels rise ...

In the fight against diseases like Alzheimer’s and Parkinson’s, scientists have long struggled to predict how certain ...

A new study indicates that the drug suvorexant could reduce proteins associated with Alzheimer's by improving sleep quality.

PMN310 is uniquely designed to selectively target toxic oligomers of amyloid-beta, which we believe is a key differentiator ... antibodies and intrabodies against a pathogenic loss-of-structure ...

The Duchess of Edinburgh visited a dementia research laboratory founded by Formula 1 world champion Sir Jackie Stewart ... Early findings suggest that even subtle shifts in amyloid beta peptides ...

Publishing in Cell Chemical Biology ... that were genetically modified to express the human equivalent of amyloid beta, which causes amyloid plaques. "The amyloid beta affects muscles and ...

We examined acetylcholinesterase, plasma neuronal proteins, secreted beta-amyloid precursor protein (APP), and amyloid-beta 40 and amyloid-beta 42 peptides in children with and without autism.